Comparison of the effects of 10 GLP-1 RA and SGLT2 inhibitor interventions on cardiovascular, mortality, and kidney outcomes in type 2 diabetes: A network meta-analysis of large randomized trials

• The relative benefit of new antidiabetic drugs for cardiorenal endpoints is unclear. • The most efficacious drugs vary with different cardiorenal endpoints. • Subcutaneous semaglutide and albiglutide are most effective for cardiac events. • Canagliflozin and empagliflozin are most effective for he...

Description complète

Détails bibliographiques

Publié dans:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
Auteur principal:	Wei, Xu-Bin (Auteur)
Autres auteurs:	Wei, Wei (Autre), Ding, Liang-Liang (Autre), Liu, Shu-Yan (Autre)
Format:	Article en ligne
Langue:	English
Publié:	2021
Accès à la collection:	A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Sujets:	CVD GLP-1 RAs ACD RCT KFP MACE CI HHF SUCRA HR plus... MI SGLT2 inhibitors
Description matérielle:	4